BiocardiaÂ Inc (BCDA) Financials

$1.08

$-0.01 (-0.92%)

As on 04-Sep-2026 16:00EDT

Market cap

$16 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

6.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	0.06	0.48	1.35	1.02
Cost of Revenue	0.54	0.51	4.39	7.73	11.90	0.64
Gross Profit	-0.54	-0.51	-4.33	-7.25	-10.55	0.38
Operating Expenses	6.85	7.77	3.67	4.40	13.25	13.01
Operating Profit (EBIT)	-7.39	-8.28	-8.00	-11.64	-11.90	-12.63
Other Income	--	--	--	--	--	--
Profit before Tax	-7.34	-8.23	-7.95	-11.57	-11.91	-12.62
Provision for Tax	--	--	-7.95	0.24	0.01	0.00
Profit after Tax (Net Income)	-7.34	-8.23	-7.95	-11.57	-11.91	-12.62
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-11.91	-12.62

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	2.70	0.90	0.84	-1.60	4.89	10.38
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.09	0.57	0.98	1.32	1.63
Current Liabilities	2.06	2.43	2.32	3.61	3.59	3.71
Total Liabilities	6.81	3.41	3.72	2.99	9.79	15.72

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.46	0.68	1.10	1.53	1.93	2.24
Current Assets	4.30	2.73	2.62	1.46	7.86	13.48
Total Assets	9.05	3.41	3.72	2.99	9.79	15.72
Total Debt*	0.29	0.53	0.95	1.32	1.63	1.87
Net Current Assets	--	0.30	0.30	-2.15	4.28	9.77

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-7.44	-8.03	-9.97	-10.56	-10.37
Cash Flow from Investing Activities	--	-0.01	-0.01	-0.01	-0.07	-0.12
Cash from Financing Activities	--	7.57	9.30	3.73	5.12	1.95
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.76	-0.76	-2.90	-7.70	-9.76	-11.09
Cash EPS ($)	-0.58	-0.76	-2.87	-7.65	-9.69	-11.04
Adjusted Book Value ($)	0.18	0.08	0.31	--	4.01	9.12
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.69	-2.92	-6.64	-8.65	-9.11
Free Cash Flow per Share ($)	--	-0.69	-2.93	-6.65	-8.71	-9.21

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-512.49	-1,059.47	-371.16	-126.96	-78.80
ROE (%)	-408.29	-950.12	2,074.67	-703.62	-156.06	-85.42
ROA (%)	-99.28	-230.57	-236.81	-181.08	-93.40	-64.49
EBIT Margin (%)	--	--	-13,700.00	-2,425.79	-880.25	-1,244.33
Net Margin (%)	--	--	-13,700.00	-2,425.79	-881.14	-1,243.45
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	-1.00	-0.88	-0.65	0.33	6.00
EBIT Growth (%)	16.55	-3.55	31.33	2.77	5.77	15.81
Net Profit Growth (%)	16.55	-3.55	31.33	2.87	5.61	15.88
EPS Growth (%)	73.18	0.74	0.62	0.21	0.12	0.34
Book Value Growth (%)	159.90	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.63	-0.75	-0.09	-0.21	-0.17
Price / Book Value	6.17	15.02	7.15	-0.62	0.52	0.21
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.16	-1.49	-0.58	-0.10	0.27	0.70
Close Price ($)	1.24	1.25	2.18	9.90	31.35	29.10
High Price ($)	2.45	3.20	10.79	43.80	42.75	82.20
Low Price ($)	0.78	1.00	1.63	5.40	16.50	24.75
Market Cap ($ Cr)	16.35	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.59	1.14	-0.82	0.33	0.18
Short term debt to equity ratio	0.11	0.49	0.46	-0.21	0.06	0.02
Current Ratio	2.09	1.12	1.13	0.40	2.19	3.63
Quick Ratio	2.09	--	--	--	2.25	3.63
Interest Coverage	--	--	--	--	-1,983.50	-1,403.33

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	13.21	14.87	14.48
Asset Turnover	--	--	0.02	0.07	0.11	0.05
Receivable days	--	--	198.37	101.08	47.01	68.19
Inventory Days	--	--	--	-9.50	-3.08	-242.55
Payable days	--	371.04	53.08	37.18	18.26	357.55
Cash Conversion Cycle	--	--	--	54.39	25.66	-531.90

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.